KIA
CNMD icon

KLR Investment Advisors’s CONMED CNMD Stock Holding History

KLR Investment Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,688
Closed -$295K – 189
2023
Q4 		$295K Sell
2,688
-16
-0.6% -$1.65K 0.21% 145
2023
Q3 		$281K Sell
2,704
-46
-2% -$5.29K 0.26% 133
2023
Q2 		$374K Sell
2,750
-53
-2% -$6.47K 0.31% 108
2023
Q1 		$292K Sell
2,803
-518
-16% -$50.1K 0.26% 130
2022
Q4 		$295K Buy
+3,321
New +$276K 0.24% 136

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

KLR Investment Advisors's CNMD Position: Q1 2024 in Review

KLR Investment Advisors sold out of CONMED (CNMD) in Q1 2024, closing a stake of 2,688 shares — an estimated $295K sold.

KLR Investment Advisors first reported a position in CNMD in Q4 2022 and held it in 5 quarters. The position peaked at $374K in Q2 2023. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • KLR Investment Advisors reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • KLR Investment Advisors sold 2,688 CONMED shares in Q1 2024, an estimated $295K.
  • KLR Investment Advisors first reported a position in CONMED in Q4 2022 and held it in 5 quarters.
  • KLR Investment Advisors's CONMED position peaked at $374K in Q2 2023.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on KLR Investment Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.